Tag Archives: astrazeneca

Bayer v. Lupin – Patenting The Label Redux

In my post of January 13, 2011, I discussed AstraZeneca LP v. Apotex, a Fed. Cir. decision in which AZ argued successfully that the proposed  Apotex labeling for an anti-asthma drug would induce infringement if the generic were marketed with … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , | Leave a comment

Astrazeneca v Apotex – Patent That Label!

I recently had a chance to re-read AstraZeneca LP v. Apotex, Inc., Appeal No. 2009-1381, 1424 (Fed. Cir. Nov. 1, 2010) and realized that it is a virtual case note on how to extend patent term by “patenting the label.” … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , | 1 Comment